InsiderTrades

Form 4 for NVCR NovoCure Ltd

Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001645113-23-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-01-09 2023-01-05 NVCR Weinberg Uri CSO S - Sale+OE $116.14 -8,143 47.1K -15% -$945.8K
D 2023-01-09 2023-01-05 NVCR Weinberg Uri CSO M - OptEx $47.04 +1,946 49.0K +4% +$91.5K
D 2023-01-09 2023-01-05 NVCR Weinberg Uri CSO M - OptEx $0.00 -1,946 1,946 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2023-01-05 S D 2,379 $120.00 47,104 D — — (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
2 Common Ordinary Shares 2023-01-05 M A 1,946 $47.04 49,050 D — — (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
3 Common Ordinary Shares 2023-01-05 S D 1,201 $120.00 43,286 D — — (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
4 Common Ordinary Shares 2023-01-05 S D 2,617 $108.00 44,487 D — — (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
5 Common Ordinary Shares 2023-01-05 S D 1,946 $120.00 47,104 D — — (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
6 Derivative Options to Buy Ordinary Shares 2023-01-05 M D 1,946 $0.00 1,946 D $47.04 · — to 2029-03-21 1,946 Ordinary Shares (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg. (F2) Fully vested as of the date hereof.